Page last updated: 2024-08-16

sb 206553 and 5,7-dihydroxytryptamine

sb 206553 has been researched along with 5,7-dihydroxytryptamine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berg, KA; Clarke, WP; De Deurwaerdère, P; Navailles, S; Spampinato, U1

Other Studies

1 other study(ies) available for sb 206553 and 5,7-dihydroxytryptamine

ArticleYear
Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Mar-31, Volume: 24, Issue:13

    Topics: 5,7-Dihydroxytryptamine; Aminopyridines; Animals; CHO Cells; Cricetinae; Dopamine; Dose-Response Relationship, Drug; Ethylamines; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Ligands; Male; Microdialysis; Neostriatum; Neural Inhibition; Neural Pathways; Nucleus Accumbens; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2004